Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brown

Showing results (521-530 of 597) with videos related to

Pageof 60
Sort By:
The Journal of Infectious Diseases|June 14, 2011
Expansion of the global measles and rubella laboratory network 2005-09David A Featherstone, Paul A Rota, Joseph Icenogle, et al.
Journal of Medicinal Chemistry|April 30, 2010
Creating an antibacterial with in vivo efficacy: synthesis and characterization of potent inhibitors of the bacterial cell division protein FtsZ with improved pharmaceutical propertiesDavid J Haydon, James M Bennett, David Brown, et al.
Environmental Health Perspectives|July 9, 2005
Personalized exposure assessment: promising approaches for human environmental health researchBrenda K Weis, David Balshaw, John R Barr, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Biphenyl amide p38 kinase inhibitors 2: Optimisation and SARRichard M Angell, Tony D Angell, Paul Bamborough, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2023
HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial CancerSherry Shen, Weining Ma, David Brown, et al.
Mabs|December 21, 2019
Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic modelsFeng Wang, Jordan C Tsai, Jonathan H Davis, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2011
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitorRobert J Young, Wendy Alderton, Anthony D R Angell, et al.
Plos Computational Biology|February 10, 2011
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture systemHung-Yun Lin, Cornelia B Landersdorfer, David London, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 24, 2020
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical ModelsDaniela Di Paolo, Fabio Pastorino, Chiara Brignole, et al.
BMJ (Clinical Research Ed.)|August 29, 2009
Monitoring the emergence of community transmission of influenza A/H1N1 2009 in England: a cross sectional opportunistic survey of self sampled telephone callers to NHS DirectAlex J Elliot, Cassandra Powers, Alicia Thornton, et al.
Pageof 60

Showing results (521-530 of 597) with videos related to

Sort By:
Pageof 60
The Journal of Infectious Diseases|June 14, 2011
Expansion of the global measles and rubella laboratory network 2005-09David A Featherstone, Paul A Rota, Joseph Icenogle, et al.
Journal of Medicinal Chemistry|April 30, 2010
Creating an antibacterial with in vivo efficacy: synthesis and characterization of potent inhibitors of the bacterial cell division protein FtsZ with improved pharmaceutical propertiesDavid J Haydon, James M Bennett, David Brown, et al.
Environmental Health Perspectives|July 9, 2005
Personalized exposure assessment: promising approaches for human environmental health researchBrenda K Weis, David Balshaw, John R Barr, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Biphenyl amide p38 kinase inhibitors 2: Optimisation and SARRichard M Angell, Tony D Angell, Paul Bamborough, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2023
HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial CancerSherry Shen, Weining Ma, David Brown, et al.
Mabs|December 21, 2019
Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic modelsFeng Wang, Jordan C Tsai, Jonathan H Davis, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2011
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitorRobert J Young, Wendy Alderton, Anthony D R Angell, et al.
Plos Computational Biology|February 10, 2011
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture systemHung-Yun Lin, Cornelia B Landersdorfer, David London, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 24, 2020
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical ModelsDaniela Di Paolo, Fabio Pastorino, Chiara Brignole, et al.
BMJ (Clinical Research Ed.)|August 29, 2009
Monitoring the emergence of community transmission of influenza A/H1N1 2009 in England: a cross sectional opportunistic survey of self sampled telephone callers to NHS DirectAlex J Elliot, Cassandra Powers, Alicia Thornton, et al.
Pageof 60